Lack of involvement of dopaminergic and GABA neurones in the inhbitory effect of harmaline on the activity of striatal cholinergic neurones in the rat.
D000109:Acetylcholine / Q000378:metabolism; D000262:Adenylyl Cyclases / Q000378:metabolism; D000470:Alkaloids / Q000494:pharmacology*; D000613:Aminobutyrates / Q000502:physiology*; D000818:Animals; D000831:Animals, Newborn; D002540:Cerebral Cortex / Q000378:metabolism; D003342:Corpus Striatum / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D003864:Depression, Chemical; D004298:Dopamine / Q000378:metabolism / Q000502:physiology*; D010134:Fenclonine / Q000494:pharmacology; D006246:Harmaline / Q000494:pharmacology*; D006624:Hippocampus / Q000378:metabolism; D008032:Limbic System / Q000378:metabolism; D008297:Male; D009434:Neural Pathways / Q000502:physiology; D009474:Neurons / Q000187:drug effects* / Q000502:physiology; D010275:Parasympathetic Nervous System / Q000166:cytology / Q000187:drug effects*; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013378:Substantia Nigra / Q000502:physiology; D003336:Tectum Mesencephali / Q000378:metabolism; D014191:Tranylcypromine / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D000470:Alkaloids; D000613:Aminobutyrates; D012701:Serotonin; D014191:Tranylcypromine; D005680:gamma-Aminobutyric Acid; D010293:Pargyline; D006246:Harmaline; D000262:Adenylyl Cyclases; D000109:Acetylcholine; D010134:Fenclonine; D004298:Dopamine